Ginkgo Datapoints signs agreement with Lilly TuneLab
Ginkgo Bioworks (NYSE: DNA) says its Ginkgo Datapoints offering entered into a new agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.